Alison Campbell

Dr. Alison Campbell

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Reproductive BioMedicine Online
Verified
Journal Article
Open access
Alison CampbellAlison Campbell
Alison Campbell
SFSimon Fishel
Simon Fishel
NBNatalie Bowman
Natalie Bowman
SDSamantha Duffy
Samantha Duffy
MSMark Sedler
Mark Sedler
CHCristina Fontes Lindemann Hickman
Cristina Fontes Lindemann Hickman
This study determined whether morphokinetic variables between aneuploid and euploid embryos differ as a potential aid to select euploid embryos for transfer. Following insemination, EmbryoScope time-lapse images from 98 blastocysts were collected and analysed blinded to ploidy. The morphokinetic variables were retrospectively compared with ploidy, which was determined following trophectoderm biopsy and analysis by array comparative genomic hybridization or single-nucleotide polymorphic array. Multiple aneuploid embryos were delayed at the initiation of compaction (tSC; median 85.1 hours post insemination (hpi); P=0.02) and the time to reach full blastocyst stage (tB; median 110.9hpi, P=0.01) compared with euploid embryos (tSC median 79.7 hpi, tB median 105.9 hpi). Embryos having single or multiple aneuploidy (median 103.4 hpi, P=0.004 and 101.9 hpi, P=0.006, respectively) had delayed initiation of blastulation compared with euploid embryos (median 95.1hpi). No significant differences were observed in first or second cell-cycle length, synchrony of the second or third cell cycles, duration of blastulation, multinucleation at the 2-cell stage and irregular division patterns between euploid and aneuploid embryos. This non-invasive model for ploidy classification may be used to avoid selecting embryos with high risk of aneuploidy while selecting those with reduced risk.

1 August 2013 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
Alison CampbellAlison Campbell
Alison Campbell
SFSimon Fishel
Simon Fishel
NBNatalie Bowman
Natalie Bowman
SDSamantha Duffy
Samantha Duffy
MSMark Sedler
Mark Sedler
STSimon Thornton
Simon Thornton

15 June 2021 in Human Reproduction Update
Verified
Journal Article
Closed access
GCGiovanni Coticchio
Giovanni Coticchio
ABAmy Barrie
Amy Barrie
CLCristina Lagalla
Cristina Lagalla
ABAndrea Borini
Andrea Borini
SFSimon Fishel
Simon Fishel
Alison CampbellAlison Campbell
Alison Campbell
BACKGROUND: IVF for the treatment of infertility offers unique opportunities to observe human preimplantation development. Progress in time-lapse technology (TLT) and preimplantation genetic testing (PGT) has greatly expanded our knowledge of developmental patterns leading to a healthy pregnancy or developmental failure. These technologies have also revealed unsuspected plastic properties of the preimplantation embryo, at macromolecular, cellular and multicellular levels. OBJECTIVE AND RATIONALE: This review focuses on the emerging concept of plasticity of the human embryo as revealed by recent evidence derived from TLT and PGT, calling for an updated and more precise redefinition of the boundaries between normal and abnormal development. SEARCH METHODS: PubMed was used to search the MEDLINE database for peer-reviewed English-language original articles and reviews concerning human preimplantation development. Cross-searches were performed by adopting ‘fertilisation‘, ‘pronucleus’, ‘cleavage’, ‘multinucleation’, ‘compaction’, ‘embryo’, ‘preimplantation genetic testing’, ‘aneuploidy’, mosaicism’, ‘micromanipulation’, ‘time-lapse microscopy’ and ‘IVF/assisted reproduction’ as main terms. The most relevant publications, i.e. those concerning major phenomena occurring during normal and abnormal development—with a focus on the human species—were assessed and discussed critically. OUTCOMES: Advances in TLT and PGT have revealed an astonishing plasticity and self-correction ability of the human preimplantation embryo in vitro. At fertilisation, an abnormal number of pronuclei do not always result in the formation of an aneuploid blastocyst. Animal studies and preliminary human observations indicate that combining of parental genomes may occur at the early cleavage stage, if not at fertilisation. Multinucleation occurs with much higher prevalence than previously thought and may be corrected at later cleavage stages. Irregular cleavage (multichotomous, direct, rapid and reverse cleavages) can generate chromosome segregation abnormalities that often lead to developmental arrest, but that sporadically may be confined to cells excluded from the blastocyst, and may sometimes result in viable pregnancy. Mitotic errors can generate mosaic blastocysts, but alternatively normal embryos may form from selective death or clonal depletion of aneuploid cells. WIDER IMPLICATIONS: Deviations from developmental dogmas and the increasing evidence of plasticity of the human embryo challenge current embryological notions and suggest the need to write new rules governing cell cycle, cell determination and chromosome segregation during preimplantation development.

28 April 2025 in Human Reproduction
Verified
Journal Article
Open access
TCThe Working Group on the update of the ESHRE/ALPHA Istanbul Consensus
The Working Group on the update of the ESHRE/ALPHA Istanbul Consensus
GCGiovanni Coticchio
Giovanni Coticchio
AAAisling Ahlström
Aisling Ahlström
GAGemma Arroyo
Gemma Arroyo
BBBasak Balaban
Basak Balaban
MAMina Alikani
Mina Alikani
STUDY QUESTION: What are the current recommended criteria for morphological assessment of oocytes, zygotes, and embryos? SUMMARY ANSWER: The present ESHRE/Alpha Scientists in Reproductive Medicine consensus document provides several novel recommendations to assess oocyte and embryo morphology and rank embryos for transfer. WHAT IS KNOWN ALREADY: A previous Alpha Scientists in Reproductive Medicine/ESHRE consensus on oocyte and embryo morphological assessment was published in 2011. After more than a decade, and the integration of time-lapse technology into embryo culture and assessment, a thorough review and update was needed. STUDY DESIGN, SIZE, DURATION: A working group consisting of Alpha Scientists in Reproductive Medicine executive committee members and ESHRE Special interest group of Embryology members formulated recommendations on oocyte and embryo assessment. PARTICIPANTS/MATERIALS, SETTING, METHODS: The working group included 17 internationally recognized experts with extensive experience in clinical embryology. Seven members represented Alpha Scientists in Reproductive Medicine and eight members represented ESHRE, along with to two methodological experts from the ESHRE central office. Based on a systematic literature search and discussion of existing evidence, the recommendations of the Istanbul Consensus (2011) were reassessed and, where appropriate, updated based on consensus within the working group. A stakeholder review was organized after the updated draft was finalized. The final version was approved by the working group, the Alpha executive committee and the ESHRE Executive Committee. MAIN RESULTS AND THE ROLE OF CHANCE: This updated consensus paper provides 20 recommendations focused on the timeline of preimplantation developmental events and morphological criteria for oocyte, zygote, and embryo assessment. Based on duration of embryo culture, recommendations are given on the frequency and timing of assessments to ensure consistency and effectiveness. LIMITATIONS, REASONS FOR CAUTION: Several criteria relevant to oocyte and embryo morphology have not been well studied, leading to either a recommendation against their use for grading or for their use in ranking rather than grading. Future updates may require further revision of these recommendations. WIDER IMPLICATIONS OF THE FINDINGS: This document provides embryologists with advice on best practices when assessing oocyte and embryo quality based on the most recent evidence. STUDY FUNDING/COMPETING INTEREST(S): The consensus meeting and writing of the paper were supported by funds from ESHRE and Alpha Scientists in Reproductive Medicine. The working group members did not receive any payment. G.C. declared payments or honoraria for lectures from Gedeon Richter and Cooper Surgical. A.C. declared text book royalties (Mastering Clinical Embryology, published 2024), consulting fees from Cooper Surgical, Gedeon Richter and TMRW Life Sciences, honoraria for lectures from Merck, Ferring, and Gedeon Richter, and participation in the HFEA Scientific Advances Committee; she also disclosed being treasurer and vice-president of Alpha Scientists in Reproductive Medicine, a shareholder in Care Fertility Limited and Fertile Mind Limited, and having stock options in TMRW Life Sciences and U-Ploid Biotechnology Ltd. L.R. declared consulting fees from Organon, payments or honoraria for lectures from Merck, Organon, IBSA, Finox, Geden Richter, Origio, Organon, Ferring, Fundation IVI; she also disclosed being a member of the Advisory Scientific Board of IVIRMA (Paid) and a member of the Advisory Scientific Board of Nterilizer (unpaid). I.S. declared payments or honoraria for lectures from Vitrolife and Cooper Surgical, and stock options from Alife Health. M.A. declared payments or honoraria for lectures from Vitrolife and support for attending meetings from Vitrolife and Cooper Surgical (both unrelated to this manuscript). The other authors have no conflicts of interest to declare. DISCLAIMER: This Good Practice Recommendations (GPRs) document represents the consensus views of the members of this working group based on the scientific evidence available at the time of the meeting. GPRs should be used for information and educational purposes. They should not be interpreted as setting a standard of care or be deemed inclusive of all proper methods of care or be exclusive of other methods of care reasonably directed to obtaining the same results. They do not replace the need for application of clinical judgement to each individual presentation, or variations based on locality and facility type.

1 November 2018 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
IGIoannis D Gallos
Ioannis D Gallos
MKMohammed Khairy
Mohammed Khairy
JCJustin Chu
Justin Chu
MRMadhurima Rajkhowa
Madhurima Rajkhowa
Aurelio TobiasAurelio Tobias
Aurelio Tobias
ACArri Coomarasamy
Arri Coomarasamy

24 February 2023 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
TBThomas Bamford
Thomas Bamford
CEChristina Easter
Christina Easter
SMSue Montgomery
Sue Montgomery
RSRachel Smith
Rachel Smith
RDRima K Dhillon-Smith
Rima K Dhillon-Smith
ACArri Coomarasamy
Arri Coomarasamy
Are machine learning methods superior to traditional statistics in predicting blastocyst ploidy status using morphokinetic and clinical biodata? Mixed effects logistic regression performed better than all machine learning methods for ploidy prediction using our dataset of 8147 embryos. Morphokinetic timings have been demonstrated to be delayed in aneuploid embryos. Machine learning and statistical models are increasingly being built, however, until now they have been limited by data insufficiency. This is a multicentre cohort study. Data were obtained from 8147 biopsied blastocysts from 1725 patients, treated from 2012 to 2020. All embryos were cultured in a time-lapse system at nine IVF clinics in the UK. A total of 3004 euploid embryos and 5023 aneuploid embryos were included in the final verified dataset. We developed a total of 12 models using four different approaches: mixed effects multivariable logistic regression, random forest classifiers, extreme gradient boosting, and deep learning. For each of the four algorithms, two models were created, the first consisting of 22 covariates using 8027 embryos (Dataset 1) and the second, a dataset of 2373 embryos and 26 covariates (Dataset 2). Four final models were created by switching the target outcome from euploid to aneuploid for each algorithm (Dataset 1). Models were validated using internal–external cross-validation and external validation. All morphokinetic variables were significantly delayed in aneuploid embryos. The likelihood of euploidy was significantly increased the more expanded the blastocyst (P < 0.001) and the better the trophectoderm grade (P < 0.01). Univariable analysis showed no association with ploidy status for morula or cleavage stage fragmentation, morula grade, fertilization method, sperm concentration, or progressive motility. Male age did not correlate with the percentage of euploid embryos when stratified for female age. Multinucleation at the two-cell or four-cell stage was not associated with ploidy status. The best-performing model was logistic regression built using the larger dataset with 22 predictors (F1 score 0.59 for predicting euploidy; F1 score 0.77 for predicting aneuploidy; AUC 0.71; 95% CI 0.67–0.73). The best-performing models using the algorithms from random forest, extreme gradient boosting, and deep learning achieved an AUC of 0.68, 0.63, and 0.63, respectively. When using only morphokinetic predictors the AUC was 0.61 for predicting ploidy status, whereas a model incorporating only embryo grading was unable to discriminate aneuploid embryos (AUC = 0.52). The ploidy prediction model’s performance improved with increasing age of the egg provider. The models have not been validated in a prospective study design or yet been used to determine whether they improve clinical outcomes This model may aid decision-making, particularly where pre-implantation genetic testing for aneuploidy is not permitted or for prioritizing embryos for biopsy. No specific funding was sought for this study; university funds supported the first author. A.Ca. is a minor shareholder of participating centres. N/A.